International Disclosure Laws: ABPI Issues EFPIA-Modeled Disclosure Template, Increases Itemized Reporting Fields

Starting in 2016, European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies will make public the details of payments and transfers of value made to healthcare professionals and healthcare organizations. EFPIA sets out the requirements for tracking and reporting this information in its Disclosure Code. EFPIA member associations are required to transpose the language from this Code into their national codes. EFPIA states that the Code only sets out the “minimum standards,” for compliance. Polaris Insights Blog recently reported that the Association of the British Pharmaceutical Industry has already added some additional requirements for its member companies. Background EFPIA states that all member associations will be required to transpose the EFPIA Code “into their national codes in full, except where its provisions are in conflict with applicable national laws or regulations, in which case deviations are allowed, but only to the extent necessary to comply with such national law or regulation.” We covered one such conflict in our article on international privacy laws, which require doctors to grant consent before companies may publish individualized transfer of value information. To facilitate the reporting process, EFPIA released a “disclosure template” in 2013, which breaks down the categories for member companies to file their information under. Companies must complete one of these templates for each European country in whi...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs